Hi-Affi™ Rabbit Anti-ASPH Recombinant Antibody (clone DS269AB)

CAT#: MOR-0269

Recombinant Rabbit anti-ASPH monoclonal antibody for WB, IHC-P, ICC/IF, FC, excellent for producing superior results. Hi-Affi™ antibodies are developed from different sources, such as B cells of immunized animals, hybridoma, phage display library. The application of recombinant technology avoids the traditional ascitic fluid approach, which achieves the antibody generation in a humane way with much larger scale, greater specificity and sensitivity, and not susceptible to cell-line drift or lot-to-lot variation.

Gene Expression
Figure 1 IF staining of human cell line HeLa Figure 2 IF staining of human cell line A549 Figure 3 IHC staining of human cerebral cortex Figure 4 Cerebral cortex Figure 5 Colon Figure 6 Pancreas Figure 7 Kidney Figure 8 Testis Figure 9 RNA cell line category: Cell line enhanced (U-87 MG)

Specifications

  • Immunogen
  • Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human Aspartate beta hydroxylase aa 250-350 (Cysteine residue). The exact sequence is proprietary.
  • Host Species
  • Rabbit
  • Derivation
  • Phage display library screening
  • Type
  • Rabbit IgG
  • Species Reactivity
  • Human
  • Clone
  • DS269AB
  • Applications
  • WB, IHC-P, IF, FC
  • Conjugate
  • Unconjugated

Product Property

  • Purification
  • Purified with Absolute Mag™ Protein A Agarose
  • Purity
  • >95% as determined by analysis by SDS-PAGE
  • Format
  • Liquid
  • Storage
  • Centrifuge briefly prior to opening vial. Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • Aspartate Beta-Hydroxylase 2; Peptide-Aspartate Beta-Dioxygenase; ASP Beta-Hydroxylase; Junctate; Junctin; Humbug; BAH; Aspartyl/Asparaginyl-Beta-Hydroxylase; Cardiac Junctin; EC 1.14.11.16; A Beta H-J-J; CASQ2BP1; FDLAB; HAAH; JCTN; AAH
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for MOR-0269. Click the button above to contact us or submit your feedback about this product.

Citations

  1. Babich, Michael, et al. "Labyrinthin: A distinct pan-adenocarcinoma diagnostic and immunotherapeutic tumor specific antigen." Heliyon 8.3 (2022). https://doi.org/10.1016/j.heliyon.2022.e08988
    This article distinguishes labyrinthin as a unique tumor-specific antigen (TSA) exclusively expressed on the surface of adenocarcinoma cells, differentiating it from the related intracellular protein aspartyl/asparaginyl β-hydroxylase (ASPH). Through immunohistochemistry, FACS analysis, confocal microscopy, and cell transfection studies, the researchers demonstrate that labyrinthin not only serves as a marker but appears functional in the cancer phenotype, with its expression promoting cancerous characteristics in normal cells and its inhibition normalizing cancer cell morphology.
    Creative Biolabs provided recombinant human IgG1 (CAT#: MHH-78-F(E)) antibodies that bind to ASPH in HEK 293 cells as well as polyclonal antibodies (CAT#: MOR-0269) targeting ASPH amino acids 250-350. These antibodies helped the researchers distinguish between ASPH and labyrinthin binding patterns, clarifying the cellular localization and expression patterns of these proteins and establishing labyrinthin as a distinct cell-surface target for potential adenocarcinoma immunotherapy approaches.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:

Protocol & Troubleshooting

We have outlined the assay protocols, covering reagents, solutions, procedures, and troubleshooting tips for common issues in order to better assist clients in conducting experiments with our products. View the full list of Protocol & Troubleshooting.

See other products for "ASPH"

Select a product category from the dropdown menu below to view related products.

CAT Product Name Application Type
MOB-78 Recombinant Anti-human ASPH Antibody WB, FC, FuncS IgG
MHH-78 Recombinant Human Anti-human ASPH Antibody IF, FACS, FuncS IgG
CAT Product Name Application Type
MOB-78-S(P) Recombinant Anti-human ASPH Antibody scFv Fragment ELISA, WB, Neut, FuncS scFv
MHH-78-S(P) Recombinant Human Anti-human ASPH Antibody scFv Fragment ELISA, WB, FC, FuncS scFv
CAT Product Name Application Type
VS-0625-FY12 Human Anti-ASPH scFv-Fc Chimera (VS-0625-FY12) FC Human IgG1, scFv-Fc
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare